Himatsingka Seide declares Q4FY22 result: FY22 Total Revenue Up 41.0% YoY to Rs 3,203.57 Crores Q4 FY22 Total Revenue Up 3.6% YoY to Rs 774.80 Crores Consolidated Total Income for FY22 stood at Rs 3,203.57 Crores vs Rs 2,272.53 Crores in FY21. This represents an increase of 41.0% YoY. Consolidated EBITDA for FY22 was Rs 549.92 Crores vs Rs 303.17 Crores FY21. The EBITDA Margin for FY22 stood at 17.2%. Consolidated EBIT for FY22 stood at Rs 391.49 Crores vs Rs 150.72 Crores in FY21, an increase of 159.8%. Consolidated PBT for FY22 stood at Rs 210.32 Crores vs a loss of Rs 26.48 Crores in FY21. Consolidated PAT for FY22 was Rs 140.82 Crores vs a loss of Rs 53.35 Crores in FY21. Consolidated Total Income for Q4 FY22 stood at Rs 774.80 Crores vs Rs 748.04 Crores in Q4 FY21. This represents an increase of 3.6% YoY. Consolidated EBITDA for Q4 FY22 was Rs 110.46 Crores vs Rs 129.66 Crores in Q4 FY21. The EBITDA Margin for Q4 FY22 stood at 14.3%. Consolidated EBIT for Q4 FY22 stood at Rs 70.49 Crores vs Rs 92.23 Crores in Q4 FY21. Consolidated PBT for Q4 FY22 stood at Rs 20.47 Crores vs Rs 52.68 Crores in Q4 FY21. Consolidated PAT for Q4 FY22 was Rs 8.04 Crores vs Rs 37.57 Crores in Q4 FY21 Commenting on the Company’s performance, Mr. Shrikant Himatsingka, Managing Director & Group CEO said: “We are pleased with our operating performance for FY22, that saw us achieve record Revenues of over Rs 3,200 crores, despite the challenging operating environment that prevailed through the fiscal. Operating profitability remained under pressure given the unprecedented levels of inflation witnessed during the fiscal. We see near term challenges on the demand and inflation front and remain focussed on price optimization, cost rationalisation, and enhancing market share across key regions.” Result PDF
Textiles firm Himatsingka Seide declares Q3FY22 result: 9M FY22 Total Revenue Up 59.3% YoY to Rs 2,428.76 Crores Q3 FY22 Total Revenue Up 16.3% YoY to Rs 792.68 Crores Consolidated Total Income for Q3 FY22 stood at Rs 792.68 Crores vs Rs 681.66 Crores in Q3 FY21. This represents an increase of 16.3% YoY. Consolidated EBITDA for Q3 FY22 was Rs 131.76 Crores vs Rs 157.34 Crores in Q3 FY21. The EBITDA Margin for Q3 FY22 stood at 16.6%. Consolidated EBIT for Q3 FY22 stood at Rs 91.57 Crores vs Rs 119.54 Crores in Q3 FY21. Consolidated PBT for Q3 FY22 stood at Rs 43.83 Crores vs Rs 74.65 Crores in Q3 FY21. Consolidated PAT for Q3 FY22 was Rs 27.05 Crores vs Rs 45.07 Crores in Q3 FY21. Consolidated Total Income for 9M FY22 stood at Rs 2,428.76 Crores vs Rs 1,524.49 Crores in 9M FY21. This represents an increase of 59.3% YoY. Consolidated EBITDA for 9M FY22 was Rs 439.45 Crores vs Rs 173.51 Crores in 9M FY21. The EBITDA Margin for 9M FY22 stood at 18.1%. Consolidated EBIT for 9M FY22 stood at Rs 320.99 Crores vs Rs 58.49 Crores in 9M FY21. Consolidated PBT for 9M FY22 stood at Rs 189.94 Crores vs a loss of Rs 79.16 Crores in 9M FY21. Consolidated PAT for 9M FY22 was Rs 132.77 Crores vs a loss of Rs 90.92 Crores in 9M FY21. Result PDF
Highlights: Q2 FY22 Total Revenue Up 23.8% YoY to Rs 816.21 Crores Q2 FY22 EBITDA Up 49.2% YoY to Rs 144.55 Crores Consolidated Total Income for Q2 FY22 stood at Rs 816.21 Crores vs Rs 659.55 Crores in Q2 FY21. This represents an increase of 23.8% YoY. Consolidated EBITDA for Q2 FY22 was Rs 144.55 Crores vs Rs 96.90 Crores in Q2 FY21. The EBITDA Margin for Q2 FY22 stood at 17.7%. Consolidated EBIT for Q2 FY22 stood at Rs 104.41 Crores vs Rs 57.62 Crores in Q2 FY21. Consolidated PBT for Q2 FY22 stood at Rs 63.34 Crores vs Rs 10.20 Crores in Q2 FY21. Consolidated PAT for Q2 FY22 was Rs 48.03 Crores vs Rs 3.81 Crores in Q2 FY21. Commenting on the Company’s performance, Mr. Shrikant Himatsingka, Managing Director & Group CEO said: “We are pleased with our operating performance for Q2 FY22. We are confident of continuing with the growth momentum during H2 FY22 and are attempting to mitigate inflationary impacts aided by pricing, enhanced capacity utilization levels and operational efficiencies. We remain focussed on improving the capacity utilization levels across our manufacturing facilities while enhancing market share across key regions. Our impetus on deleveraging and improving capital efficiencies will be central to our operating strategy going forward.” Result PDF